Company Monitoring Page for Celgene

latest headlines for company on cafepharma

Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/20/18 - 11:16 pm
Tags:
earnings, biotech, Biogen, Alexion Pharmaceuticals, Bristol-Myers Squibb, Celgene, Gilead Sciences, Merck, Biomarin, Galapagos, Seattle Genetics, Dr Reddy's
Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
CP Wire
Wed, 10/10/18 - 10:10 am
Tags:
Celgene, ozanimod, multiple sclerosis
Wed, 10/10/18 - 09:50 am
Tags:
Celgene, ozanimod, multiple sclerosis
Celgene notches positive Otezla data in scalp psoriasis as it guns for market expansion
Fierce Pharma
Tue, 10/9/18 - 11:23 pm
Tags:
Celgene, Otezla, scalp psoriasis, FDA
Drumbeat of bad news continues at OncoMed as Celgene dumps option on one of its last pipeline efforts
Endpoints
Thu, 09/20/18 - 11:11 am
Tags:
OncoMed, Celgene, navicixizumab
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Motley Fool
Fri, 09/14/18 - 11:59 pm
Tags:
Bluebird Bio, Amgen, Celgene, AMG-420, bb2121
Celgene's CEO Wants to Make the Biotech's Best-Selling Drug Obsolete
Motley Fool
Fri, 09/7/18 - 11:28 am
Tags:
Revlimid, Celgene, Pharma CEOs, Mark Alles
The reinvention of Bob Hugin: Amid anger over drug prices, a former pharma CEO makes a run for the Senate
Stat
Thu, 09/6/18 - 09:33 am
Tags:
Bob Hugin, Celgene, Pharma CEOs, Senate, politics
Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review
Yahoo/Zacks.com
Fri, 08/24/18 - 11:08 am
Tags:
Bristol-Myers Squibb, Empliciti, Celgene, Pomalyst, Multiple Myeloma
Can Celgene’s Most Important Drugs Keep Growing?
Motley Fool
Sun, 07/29/18 - 11:01 am
Tags:
Celgene, Multiple Myeloma
Celgene (CELG) Beats on Q2 Earnings, Ups View
Marketwatch
Thu, 07/26/18 - 11:06 pm
Tags:
Celgene, earnings
BeiGene Initiates Ph III Trial of PD-1 Inhibitor Tislelizumab + Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer in China
CP Wire
Wed, 07/25/18 - 03:11 pm
Tags:
BeiGene, Celgene, tislelizumab, China, monoclonal antibodies
Can Celgene's latest Revlimid win reverse the company's bad-news streak?
Fierce Pharma
Tue, 07/24/18 - 06:00 pm
Tags:
Celgene, Revlimid, clinical trials, Roche, Rituxan, non-Hodgkin lymphoma
Number 7? Celgene partner BeiGene joins the crowd with stellar PD-1/L1 data from a pivotal test
Endpoints
Mon, 07/23/18 - 09:45 am
Tags:
Celgene, BeiGene, tiselizumab, Hodgkin's lymphoma
7 companies to watch during Q2 earnings
Biopharma Dive
Sun, 07/22/18 - 12:41 pm
Tags:
earnings, Biogen, Gilead Sciences, Amgen, Celgene, AbbVie, Pfizer, Spark Therapeutics
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Medical Marketing and Media
Wed, 07/18/18 - 10:49 pm
Tags:
Celgene, Novartis, ozanimod, Gilenya, MS, multiple sclerosis, patents
Takeda, Celgene Invest $6 Million in Presage Biosciences Cancer Testing Technology
BioSpace
Tue, 07/17/18 - 11:23 pm
Tags:
Presage Biosciences, Takeda, Celgene, cancer, diagnostics
Many Drugmakers Ignore Trump—and Raise Prices Anyway
Bloomberg
Sun, 07/15/18 - 12:52 pm
Tags:
drug pricing, Donald Trump, Pfizer, Celgene, Roche, Novo Nordisk
MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too
Fierce Pharma
Fri, 07/13/18 - 11:52 am
Tags:
patents, Novartis, MS, Gilenya, Celgene, exclusivity
Celgene tweaks trial of myeloma CAR-T bb2121, raising dose
Fierce Biotech
Fri, 07/13/18 - 09:44 am
Tags:
Celgene, clinical trials, bb2121, Bluebird Bio, Multiple Myeloma, CAR-T

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.